Wealth Enhancement Advisory Services’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,073
Closed -$25.4K – 4321
2026
Q2
$25.4K Buy
+11,073
New +$16K ﹤0.01% 4008
2026
Q1
– Sell
-136,587
Closed -$325K – 3720
2025
Q4
$325K Sell
136,587
-883
-0.6% -$2.42K ﹤0.01% 2854
2025
Q3
$392K Buy
+137,470
New +$471K ﹤0.01% 2562

Other funds holding HCAT

Wealth Enhancement Advisory Services's HCAT Position: Q3 2026 in Review

Wealth Enhancement Advisory Services sold out of Health Catalyst (HCAT) in Q3 2026, closing a stake of 11,073 shares — an estimated $25.4K sold.

Wealth Enhancement Advisory Services first reported a position in HCAT in Q3 2025 and held it in 3 quarters. The position peaked at $392K in Q3 2025. 48 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • Wealth Enhancement Advisory Services reported no remaining Health Catalyst position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 11,073 Health Catalyst shares in Q3 2026, an estimated $25.4K.
  • Wealth Enhancement Advisory Services first reported a position in Health Catalyst in Q3 2025 and held it in 3 quarters.
  • Wealth Enhancement Advisory Services's Health Catalyst position peaked at $392K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.